Hikma Pharmaceuticals

Pharmaceuticals
HIK.L
GBX 1,738 2
Share price
$ 4.9 bn
Market Cap
$ 5.5 bn
Enterprise Value

Carbon footprint

22 Ton
GHG emissions per $ 1 mln investment
0.79x the weighted average for S&P 500
FY2020
How is this calculated?
-0.4%
YOY change in GHG emissions
Weaker than the -8.7% weighted average for S&P 500
FY2020 vs. previous year

Primary Climate Goal

This company has not set a company-wide target for an absolute reduction in GHG emissions yet

GHG emissions and Carbon intensity

Hikma Pharmaceuticals's GHG emissions (location-based) (Kt of CO2e)
Hikma Pharmaceuticals's Carbon intensity (Tons per 1 USDm)

Hikma Pharmaceuticals's carbon footprint

Hikma Pharmaceuticals reported Total CO2e Emissions - Location-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2020 at 124 Kt (-0.44 /-0.4% y-o-y). Also positively, carbon intensity decreased to 53 t (-3.5 /-6.2% y-o-y).

Hikma Pharmaceuticals reported Scope 3 emissions for the the twelve months ending31 December 2020 at 0.8

The company has not set a company-wide target for an absolute reduction in GHG emissions yet.

Company environmental metrics

Show more...